Serum leptin levels are positively associated with aortic stiffness in patients with chronic kidney disease stage 3–5

References

• Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305.
   PubMed Web of Science ®Google Scholar
• Matsushita K, van der Velde M, Astor BC, et al. Chronic kidney disease prognosis consortium, association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073–2081.
   PubMed Web of Science ®Google Scholar
• Dumor K, Shoemaker-Moyle M, Nistala R, et al. Arterial stiffness in hypertension: an update. Curr Hypertens Rep. 2018;20:72.
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318–1327.
   PubMed Web of Science ®Google Scholar
• Cavalcante JL, Lima JA, Redheuil A, et al. Aortic stiffness: current understanding and future directions. J Am Coll Cardiol. 2011;57:1511–1522.
   PubMed Web of Science ®Google Scholar
• Lioufas N, Hawley CM, Cameron JD, et al. Chronic kidney disease and pulse wave velocity: a narrative review. Int J Hypertens. 2019;2019:9189362.
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Xaplanteris P, Aboyans V, et al. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European society of cardiology working group on peripheral circulation: endorsed by the association for research into arterial structure and physiology (ARTERY) society. Atherosclerosis. 2015;241:507–532.
   PubMed Web of Science ®Google Scholar
• Mancia G, Fagard R, Narkiewicz K, et al. ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). J Hypertens. 2013;2013(31):1281–1357..
   Web of Science ®Google Scholar
• Wang H, Luo W, Eitzman DT. Leptin in thrombosis and atherosclerosis. Curr Pharm Des. 2014;20(4):641–645.
   PubMed Web of Science ®Google Scholar
• Beltowski J. Leptin and atherosclerosis. Atherosclerosis. 2006;189(1):47–60.
   PubMed Web of Science ®Google Scholar
• Koh KK, Park SM, Quon MJ. Leptin and cardiovascular disease: response to therapeutic interventions. Circulation. 2008;117(25):3238–3249.
   PubMed Web of Science ®Google Scholar
• Chen MC, Wang JH, Lee CJ, et al. Association between hyperleptinemia and cardiovascular outcomes in patients with coronary artery disease. Ther Clin Risk Manag. 2018;14:1855–1862.
   PubMed Web of Science ®Google Scholar
• Katsiki N, Mikhailidis DP, Banach M. Leptin, cardiovascular diseases and type 2 diabetes mellitus. Acta Pharmacol Sin. 2018;39(7):1176–1188.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612..
   PubMed Web of Science ®Google Scholar
• Eknoyan G, Levin A, Levin NW, National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4 Suppl 3):S1–S201..
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13–S28..
   PubMedGoogle Scholar
• Tsai JP, Lee MC, Chen YC, et al. Hyperleptinemia is a risk factor for the development of central arterial stiffness in kidney transplant patients. Transplant Proc. 2015;47:1825–1830.
   PubMed Web of Science ®Google Scholar
• Tsai JP, Wang JH, Chen ML, et al. Association of serum leptin levels with central arterial stiffness in coronary artery disease patients. BMC Cardiovasc Disord. 2016;16:80.
   PubMed Web of Science ®Google Scholar
• Tsai JP, Hsu BG, Lee CJ, et al. Serum leptin is a predictor for central arterial stiffness in hypertensive patients. Nephrology. 2017;22:783–789.
   PubMed Web of Science ®Google Scholar
• Kuo CH, Lin YL, Lee CJ, et al. Hyperleptinemia positively associated with central arterial stiffness in hemodialysis patients. PLoS One. 2018;13:e0190694.
   PubMed Web of Science ®Google Scholar
• Lim S, Meigs JB. Ectopic fat and cardiometabolic and vascular risk. Int J Cardiol. 2013;169(3):166–176.
   PubMed Web of Science ®Google Scholar
• Jordan J, Nilsson PM, Kotsis V, et al. Joint scientific statement of the European association for the study of obesity and the European society of hypertension: obesity and early vascular ageing. J Hypertens. 2015;33(3):425–434..
   PubMed Web of Science ®Google Scholar
• Safar ME. Arterial stiffness as a risk factor for clinical hypertension. Nat Rev Cardiol. 2018;15:97–105.
   PubMed Web of Science ®Google Scholar
• van Varik BJ, Vossen LM, Rennenberg RJ, et al. Arterial stiffness and decline of renal function in a primary care population. Hypertens Res. 2017;40(1):73–78..
   PubMed Web of Science ®Google Scholar
• Dhillon SS, Belsham DD. Leptin differentially regulates NPY secretion in hypothalamic cell lines through distinct intracellular signal transduction pathways. Regul Pept. 2011;167(2–3):192–200.
   PubMedGoogle Scholar
• Werner N, Nickenig G. From fat fighter to risk factor: the zigzag trek of leptin. Arterioscler Thromb Vasc Biol. 2004;24(1):7–9.
   PubMed Web of Science ®Google Scholar
• Sabbatini AR, Faria AP, Barbaro NR, et al. Deregulation of adipokines related to target organ damage on resistant hypertension. J Hum Hypertens. 2014;28(6):388–392..
   PubMed Web of Science ®Google Scholar
• Correia ML, Morgan DA, Sivitz WI, et al. Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure. Hypertension. 2001;37:936–942.
   PubMed Web of Science ®Google Scholar
• Loffreda S, Yang SQ, Lin HZ, et al. Leptin regulates proinflammatory immune responses. Faseb J. 1998;12(1):57–65..
   PubMed Web of Science ®Google Scholar
• Parhami F, Tintut Y, Ballard A, et al. Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res. 2001;88(9):954–960..
   PubMed Web of Science ®Google Scholar
• Muoio DM, Dohm GL, Tapscott EB, et al. Leptin opposes insulin’s effects on fatty acid partitioning in muscles isolated from obese ob/ob mice. Am J Physiol. 1999;276:E913–921.
   PubMedGoogle Scholar
• Hasan-Ali H, Abd El-Mottaleb NA, Hamed HB, et al. Serum adiponectin and leptin as predictors of the presence and degree of coronary atherosclerosis. Coron Artery Dis. 2011;22(4):264–269..
   PubMed Web of Science ®Google Scholar
• Abdelhafiz AH, Ahmed S, El Nahas M. Microalbuminuria: marker or maker of cardiovascular disease. Nephron Exp Nephrol. 2011;119(Suppl 1):e6–10.
   PubMedGoogle Scholar
• Kaewboonchoo O, Sembajwe G, Li J. Associations between job strain and arterial stiffness: a large survey among enterprise employees from Thailand. Int J Environ Res Public Health. 2018;15(4):pii: E659.
   PubMed Web of Science ®Google Scholar